HRT FINANCIAL LP

Position in NVS — Novartis AG

CIK 1475597 NEW YORK, NY

Position in NVS

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,801,336

-$17,935,386 QoQ

Shares Held

24,886

-84.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $579,743,845 across 13 Drug Manufacturers - General names. NVS ranks #8 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	926,410	$201,484,910
2	BMY	Bristol Myers Squibb Co	2,075,945	$125,906,064
3	AMGN	Amgen Inc	321,715	$113,195,422
4	LLY	ELI LILLY & Co	53,051	$48,794,718
5	GILD	Gilead Sciences, Inc.	270,699	$37,727,319
6	GSK	GSK plc	425,687	$23,493,665
7	MRK	Merck & Co., Inc.	142,729	$17,168,871
8	NVS	Novartis AG This page	24,886	$3,801,336

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,801,336	24,886	-84.2%	Shares	Defined	2026-05-14
2025-12-31	$21,736,722	157,661	+13.5%	Shares	Defined	2026-02-12
2025-09-30	$17,807,278	138,859	+265.6%	Shares	Defined	2025-11-14
2025-06-30	$4,595,959	37,980	-18.7%	Shares	Defined	2025-08-14
2025-03-31	$5,205,893	46,698	-17.7%	Shares	Defined	2025-05-15
2024-12-31	$5,520,201	56,728	+185.8%	Shares	Defined	2025-02-14
2024-09-30	$2,282,686	19,846	+374.9%	Shares	Defined	2024-11-12
2023-09-30	$425,672	4,179	+11.1%	Shares	Defined	2023-11-13
2022-12-31	$341,288	3,762	-76.5%	Shares	Defined	2023-02-10
2022-03-31	$1,407,334	16,038	-26.1%	Shares	Defined	2022-05-16
2021-12-31	$1,899,236	21,713	-22.2%	Shares	Defined	2022-02-14
2021-09-30	$2,281,662	27,900	+17.0%	Shares	Defined	2021-11-15
2021-03-31	$2,038,527	23,848	+133.3%	Shares	Defined	2021-05-17
2020-12-31	$965,357	10,223	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.